Program

CANNABIS: FROM FONDAMENTAL TO EXPERIMENTAL ASPECTS (see the abstract)


Chair: Michel Mallaret (Grenoble) and Michel Reynaud (Paris)
Moderation: Amine Benyamina (Paris)

Use in general population, relationship with profession and social category

Jean-Michel Costes (OFDT - Paris)

Cannabis users: functions and logic of use in regular users
Catherine Reynaud-Maurupt (Paris)

Collaboration of a CEIP and a CSST, pratice and public specificity
Jocelyne ARDITTI, Jean Jacques SANTUCCI and Xavier THIRION (Marseille)

Clinic and comorbidity
Amine BENYAMINA and Laurent KARILA (Paris)

Experimental aspects of Cannabis psychocomportemental effects
Joëlle MICALLEF-ROLL (Marseille)

Seeking new therapeutics for young cannabis dependent users: multidimensional
familial therapy and the INCANT project: Philip Nielsen (Genève)

SOCIETY DEBATE: DRUG ADDICTION, HEPATITIS, AIDS: WHAT
ABOUT SOLIDARITIES BETWEEN NORTHERN AND SOUTHERN COUNTRIES ?
(see the abstract)

• WORKSHOPS 1 (see the abstract)
  
  HCV, ADDICTIONS AND PSYCHIATRIC DISORDERS : TENDING TO AN EVOLUTION OF PRACTICES Symposium organised by the Roche laboratories
  
  Moderation : Laurent MICHEL (Limeil-Brevannes) and Pascal MELIN (Saint Dizier)
  
  2:30-3:30 PM : Tracks to improve the care of drug users with HCV: conclusions of workshops MICADO
  
  Introduction
  Monelle Muntlak (Neuilly sur Seine)
  
  Detecting and diagnosis of HCV in drug users
  Jean-François Roch (Besançon)
  
  Preparation and treatment of HCV
  Isabelle Fouchard-Hubert (Angers) et Georges Bonnemaison (Tours)
  
  Following drug users after initialization of a treatment against HCV
  Jacques Bertrou (Châteauroux)
  
  3:30 - 4:30 PM: National survey of c’Psy practices: necessity of a new consensus.
  
  What are the current recommendations?
  Marc SCHOEFFLER (Erstein) and Aurélie GAUCHET (Grenoble)
  
  What about psychological aspects in HCV nowadays?
  Pascal MELIN (St Dizier)
  
  Results of the C’PSY national survey
  Laurent MICHEL (Limeil-Brevannes)
  
  
• WORKSHOP 2 (see the abstract)
  
  

  MEDICATIONS AND ADDICTION: TECHNICAL AND SOCIAL ASPECTS
  Symposium organised by Société d'Addictologie Francophone (SAF)
  
  Chair : Jean TIGNOL (Bordeaux) and Boyan CHRISTOPHOROV (Paris)
  Coordination : Didier TOUZEAU (Bagneux) - Animation : F. ARNOLD-RICHEZ (Chatou)
  

  Broughts of neurobiology in pharmacotherapies development
  Florence Noble (Paris)
  
  About a new medication treating addictions (varenicline):
  Ivan Berlin (Paris)
  
  The medication, between social and technical aspects (buprenorphine)
  Isabelle Feroni (Marseille)
  
  Medical, legal and reglementary aspects of risk management
  Maria Boulos (Saint-Denis)
  
  Relational and psychological aspects
  Jérôme Lacoste (Fort de France)
  
  Conclusions
  Aimé Charles-Nicolas (Fort de France)
  
  

• WORKSHOP 3 (see the abstract)
  
  

  NON PHARMACOLOGICAL THERAPEUTICS OF ADDICTIONS PSYCHANALYSIS AND ADDICTIONS
  
  Chair: Charles MELMAN (Paris)
  Moderation: Jean-luc VENISSE (Nantes)
  Discussion: Laurent GOURARIER (Paris)
  

  Hypothesis of belgium analysts about substitution functionning
  Myriam SWARTEBROECKX (Bruxelles)
  Pulsional economy in drug addicts
  Jean-François DAUBECH (Bordeaux)
  Drugs function in psychotics
  Jacques JUNGMAN (Paris)

  
  

• WORKSHOP 4 (see the abstract)
  
  

  HYGIENIC CONSUMPTION ROOMS
  
  Chair: Celina PEREDA (Bilbao)
  

  An hygienic consumption room in Bilbao
  Jose Julio PARDO (Bilbao)
  
  MSIC, the Sidney experience
  Ingrid VAN BEEK (Sidney)
  
  Beginnings of an hygienic consumption room in Switzerland
  Christophe MANI (Genève)
  
  INSITE, harm reduction in Vancouver
  Sarah EVANS (Vancouver)
  
  

• WORKSHOP 5 (see the abstract)
  
  

  HEALTH INTERVENTION OF PREVENTION AND HARM REDUCTION IN FESTIVE PLACES
  
  Chair: J-M PRIEZ (Paris)
  Moderation: Jean-Luc PRADEILLE (Bayonne)
  Discussion: Hervé GALVIN (La Ciotat)
  

  Presentation of national intervention plans
  Sébastien PETIT (Paris)
  
  Presentation of european intervention plans
  Stéphane LECLERC (Barcelone)
  
  Marquis’ reaction in harm reduction in festive place: an undervalued on-site pill testing of ecstasy tablets: Jean-Luc PRADEILLE (Bayonne)
  
  Specificity of medicine in festive places: hallucinated clinics
  Hans GADELIUS (Marseille)
  
  Role of a reinsurance plan in festive places
  Alexandre PEYRE (Paris)

   

Chair: Wilson COMPTON (USA) and Joël SWENDSEN (Bordeaux)

Wilson COMPTON (Bethesda) - Elizabeth ROBERTSON (Bethesda)
Mary ANN PENTZ (Los Angeles) - Philip FISHER (Eugene)
Mary JANE ROTHERAM-BORUSA (Los Angeles) - Linda COLLINS (State College)

PLENARY SESSION: ENDING OF AN OPIATE SUBSTITUTION TREATMENT(see the abstract)

Chair : Marta TORRENS (Barcelone)

How to end opiate substitution treatments? Marc REISINGER (Bruxelles)

Round table: Bertrand LEBEAU (Paris) - Jean-Jacques DEGLON (Genève) - Fabrice OLIVET (Paris) - Marta TORRENS (Barcelone)

PLENARY SESSION: NIDA - HIV, HCV AND DRUG ADDICTION (see the abstract)

Chair: Jacques NORMAND (Bethesda) and Christian TREPO (Lyon)

Epidemiology of HIV and HCV among Drug Users
Steffanie STRATHDEE (San Diego)

Pathogenesis and Natural History of HCV
David THOMAS (Baltimore)

Effects of HIV and HCV on Central Nervous System Function
Igor GRANT (San Diego)

Managing the treatment of HCV and HCV/HIV co-infection
Diana SYLVESTRE (San Francisco)

HCV Medications and Therapeutic Trials
Ken SHERMAN (Cincinnati)

• WORKSHOP 1 (see the abstract)
  
  

  COCAÏNE, DRUG OF THE FUTURE
  
  Chair: Aimé CHARLES-NICOLAS (Fort de France)
  Moderation: Joan COLOM (Barcelone)
  

  New clinic of cocaine addiction
  Aimé CHARLES-NICOLAS (Fort de France)
  
  Cocaïne and attention deficit hyperactivity disorder
  Jose Antonio RAMOS-QUIROGA (Barcelone)
  
  Cocaïne Addiction: 4 clinical observations
  Xavier AKNINE (Aulnay sous Bois)
  
  Cocaïne consumption and patients in subsitution treatments
  Didier TOUZEAU (Bagneux)
  
  Medications for cocaine addiction
  Jérôme LACOSTE (Fort de France)
  
  Cocaine, recent trends
  Agnès CADET TAIROU (Saint Denis)
  
  Little cocaine traffic
  Michel GANDILHON (Saint Denis)
  
  

• WORKSHOP 2 (see the abstract)
  
  

  ADDICTIONS WITHOUT SUBSTANCES
  
  Chair: Marina CROQUETTE-KROKAR (Genève) and Jean-Luc VENISSE (Nantes)
  
  Internet addiction: from evaluation to therapy, therapeutic program
  of the Phenix foundation: Marina CROQUETTE-KROKAR (Genève)
  
  Sexual addictions
  Florence THIBAULT (Rouen)
  
  What about the concept of addiction in eating disorders?
  JLuc VENISSE (Nantes)
  
  What is the addictive dimension related to video games practice ?
  Bruno ROCHER (Nantes)
  
  Addictive dimension of eating disorders
  Jean VIGNAU (Lille)
  
  

• WORKSHOP 3 (see the abstract)
  
  

  WHICH NEW PROSPECTS IN THE TREATMENT FOR OPIATE ADDICTION: FROM ASSESSMENT TO PRACTICE Summary and evidences with international experts
  Symposium sponsorised by the Schering Plough laboratories
  

  Chair : Charles O’BRIEN (Philadelphie) and Marc AURIACOMBE (Bordeaux)
  

  A new pharmacological and therapeutical concept
  Eric Strain (Baltimore)
  
  The Australian experience
  A. Dunlop (Wallsend)
  
  The British practice
  J. Crichton (Southampton)
  
  Learnings from the American experience
  C R. Schuster (Chicago)
  
  Perspectives within the French background
  P. Poloméni (Paris)
  
  Development in France
  A. Rimailho (Levallois-Perret)

  
  

• WORKSHOP 4 (see the abstract)
  
  SPORT, DOPING AND ADDICTIONS
  
  Chair : Christian DAULOUEDE (Bordeaux) and Serge SIMON (Bordeaux)
  
  Steroids use: a summary
  Eric MANGON (Bordeaux)
  
  Anorexia Athletica’s place in female sport athletes
  Sabine AFFLELOU (Bordeaux)
  
  Consumption of anabolic steroids in sport, physical activity and as a drug
  of abuse: an analysis of the scientific literature and areas of research
  Victor AGULLO (Valencia)
  
  Adolescents and sport addiction
  Estelle CHEDHOMME (Bordeaux)
  
  
• WORKSHOP 5 (see the abstract)
  
  HEPATITIS
  
  Chair: Pascal MELIN (St Dizier)
  Moderation: Aurélie GAUCHET (Grenoble)
  
  Is there a place for hepatologists in the treatment of drug users with HCV?
  Anne GERVAIS (Paris)
  
  Results from the HCV survey and drug users ASUD/SOS Hépatites
  Michel BONJOUR
  
  HCV and drug users according to an anthropologist
  Catherine ENEL (Dijon)
  
  HCV and psychiatric disorders – Results of CHEOPS study
  J.P. LANG (Strasbourg)
  
  PEGAPSY study – First Results
  J.P. BRONOWICKI (Nancy)
  
  Reflection for a psychological clinic of patients with HCV. The GRAPH group
  (Groupe de Réflexion et d’Analyse des Psychologues dans l’Hépatite C)
  Présentation collective
  
  

SOCIETY DEBATE: SPORT, DOPING, BODY IMAGE
AND ADDICTION: A SOCIETY BREAKER

Following this debate, a reception will be offered with Mr Didier BOROTRA,
senator and mayor of Biarritz; and then, a bask party will take place.

Chair : Jean-Louis SAN MARCO (Marseille) and Christian TREPO (Lyon)

Drug addiction, hepatitis and AIDS in prisons
Fadi MEROUEH (Villeneuve les Maguelone)

COQUELICOT study
Marie JAUFFRET ROUSTIDE (Paris)

Non invasive methodology of liver stiffness measurement: Fibroscan
Victor DE LEDINGHEN (Bordeaux)

The ESTHER project: Solidarity between Northern and Southern countries in
the field of Drug addiction, hepatitis and AIDS: Gilles RAGUIN (Paris)

RELATIONSHIPS BETWEEN ACCESS TO OPIATE SUBSTITUTION TREATMENTS (OST) AND OST DIVERSION: WICH BENEFITS ON PUBLIC HEALTH?

Chair: Jean-Louis SAN MARCO (Marseille) et Anne COPPEL (Paris)
Moderation: Patrizia CARRIERI (Marseille)

Misuse of buprenorphine by sniffing and injecting : Results of the SUBAZUR survey
Perrine ROUX (Marseille)

Access to OST and needle-exchange programs
Charlotte VAN DEN BERG (Pays Bas)

Experience of suboxone use in Finland
Hannu ALHO (Helsinki)

Access to OST and Traffic
Carlos NORDT (Zurich)

• WORKSHOPS 1 (see the abstract)
  
  HEP’TOX : A NATIONAL PROGRAM TO OPTIMIZE PREVENTION AND CARE OF DRUG USERS
  WITH HCV IN ADDICTION CENTERS
  Symposium sponsorised by the Schering-Plough Laboratories
  
  Joseph MOUSSALLI (Paris) and Jean-Louis BOUJENAH (Paris)
  
  
• WORKSHOPS 2 (see the abstract)
  
  

  RIGHTS OF DRUG USERS IN SUBSTITUTION TREATMENTS
  
  Chair: Fabrice OLIVET (Paris) and Jean-Pierre COUTERON (Paris)
  

  Laurent MICHEL (Limeil Brevannes) - Laurent GOURARIER (Paris)
  Pierre CHAPPARD (Paris)
  
  

• WORKSHOPS 3 (see the abstract)
  
  

  METHODOLOGY OF CLINICAL TRIALS WITH DIACETYLMORPHINE

  
  Chair: Wim VAN DEN BRINK (Amsterdam) and Miguel CASAS (Barcelone)
  
  Wim VAN DEN BRINK (Amsterdam) - Ambros UCHTENHAGEN (Zurich)
  Miguel MARSET (Genève) - Wilfried Köhler (Frankfurt)
  Joan COLOM (Barcelone) - Joan Carles MARCH (Grenade)
  
  
• WORKSHOPS 4 (see the abstract)
  
  PRISONS
  
  

  Chair: Saâdia YAKOUB (Paris) and Philippe CHOSSEGROS (Lyon)
  Discussion : Gabriel MOUESCA (Bayonne) - Président de l’OIP
  

  The problem of care consent in prisons
  Pierre LAMOTHE (Lyon)
  
  Following of the treatment evolution of HCV patients in jail between 2006
  and 2010. Analysis of RECAMS study after 1 year.
  Jean-Noël MARZO et Ludovic LEVASSEUR (Aulnay sous Bois)
  
  Social and medical profiles of prisoners in substitution treatments
  Ivana OBRADOVIC (Paris)
  
  Addiction problems in emprisoned minors
  Betty BRAHMY (Paris)
  
  Pregnant drug user woman co infected after emprisonment or police custody
  Malika SANA (Paris)
  
  Needle-exchange programs in prison – European and national situation
  Philippe Philippe CHOSSEGROS (Lyon)
  
  

• WORKSHOPS 5 (see the abstract)
  
  

  DRUG ABUSE AND PSYCHIATRIC COMORBIDITIES: THE CASE OF HYPERACTIVITY
  

  Chair: Manuel BOUVARD (Bordeaux) and Véronique Gaillac (Paris)
  Moderation: Franck BAYLE (Paris)
  

  Attention deficit hyperactivity disorder in the detecting of psychiatric disorders among tobacco and cannabis young smokers: Diane PURPER-OUAKIL (Paris)
  
  Adolescence, risk behavior et executive function
  Mario SPERANZA (Versailles)
  
  Clinical guidances and specificity of Attention deficit hyperactivity disorder in adults
  François BANGE (Paris)
  
  The Attention deficit hyperactivity disorder in adults: how to detect and diagnose?
  Hervé CACI (Nice)
  
  Attention deficit hyperactivity disorder and drug abuse: differential diagnosis therapeutical targets : Jacques BOUCHEZ (Villejuif)
  
  Treatments of Attention deficit hyperactivity disorder in adults: interests and borderline cases: Franck BAYLE (Paris)

  
  

• WORKSHOPS 6 (see the abstract)
  
  

  PARENTHOOD, OPIATE OR POLYDRUG ABUSERS: MEDICAL, PSYCHIATRICAL OR SOCIAL ISSUES
  
  Chair : Laurent GOURARIER (Paris) - Moderation : Nina EBNER (Vienne)
  

  Place of a possible therapeutic choice in the substitution treatment of pregnant drug-abusing women: What’s up with the international, prospective, double-blind, multi-center Study funded by NIDA? Hendree JONES (Bethesda)
  
  Australian specificities in parenthood among drug abusers: Why was the International Consortium created? Adrian DUNLOP (Wallsend)
  
  Why did a paediatrician publish about buprenorphine in French pregnant opiate abusers? Evelyne MAZURIER (Montpellier)
  
  Backgrounds of searching for a new treatment among opiate dependent women during pregnancy in Belgium, twenty years ago? Marc Reisinger (Bruxelles)
  
  Parenthood among opiate and poly-drug abusers. What beside the treatment?
  Ahcène CHEMALI (Paris)